prostate cancer

Ultra-marathon runner to terminal in 36 hours! Quite a headline, don’t you think?

The moment those three harrowing words, “You have cancer,” left the doctor’s lips, fear seized my heart like a vice grip, squeezing tighter with each passing second.

Transgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been unclear.

Choosing the right treatment plan is crucial to ensure a successful recovery and a better quality of life. 

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body.

Many employees in the offshore sector work night shifts. This may make them more susceptible to aggressive prostate cancer than if they only worked during the day.

The researchers analysed data from the PROSPER trial, published in 2018, which enrolled men with nmCRPC and rapidly rising PSA levels.

For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα.

In men undergoing active surveillance as an alternative to immediate treatment for prostate cancer, a supervised exercise programme can reduce anxiety.

The risk of developing some cancers appears to be decreased in patients with schizophrenia.